Results 241 to 250 of about 331,534 (287)

Traditional Chinese medicine in the treatment of diabetic kidney disease: the mechanisms of signaling pathways regulations. [PDF]

Front Endocrinol (Lausanne)
Li W, Lei C, Wu Q, Chen K, Liu Z, Xing Q, Liu X, Zhang J.   +7 more
europepmc   +1 more source

Patients on statins with elevated transaminases: Frequency of follow‐up creatine kinase testing and gastroenterology referral

British Journal of Clinical Pharmacology, EarlyView.
Abstract Purpose To quantify how often creatine kinase (CK) is measured after newly elevated aminotransferases in statin users, and whether absent CK data are associated with gastroenterology (GI) referrals. Methods Retrospective chart review of adult outpatients on statins with a first alanine/aspartate aminotransferase (ALT/AST) elevation during a 5 ...
Faris Shweikeh, Anas Kartoumah, Rajshri Joshi, Anjali Nadihaan, Mohammed Mouchli, Inderprit Singh   +5 more
wiley   +1 more source

Targeting mitochondrial quality control in diabetic kidney disease: emerging therapeutic opportunities. [PDF]

Ren Fail
Luo J, Lu F, Cuciureanu M, Xu X, Dong H, Gong M.   +5 more
europepmc   +1 more source

Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiators

British Journal of Clinical Pharmacology, EarlyView.
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen, Sean Hennessy, Colleen M. Brensinger, Warren B. Bilker, Laura M. Dember, Todd A. Miano, Tat‐Thang Vo, Allison W. Willis, Charles E. Leonard   +8 more
wiley   +1 more source

Unraveling the role of mitochondrial dysfunction in diabetic kidney disease: insights and interventions. [PDF]

Front Pharmacol
Fan Z, Luo P, Gao Y, Ma H, Fan J, Sanan S, Zhang P, Lu K, Xia H.   +8 more
europepmc   +1 more source

Visceral fat score predicts diabetic kidney disease: analysis of 20 years of U.S. NHANES data. [PDF]

Ren Fail
Xu M, Yan H, Gu T, Yang Q, Xue Y.
europepmc   +1 more source

Unveiling the gut-kidney dialogue in diabetic kidney disease. [PDF]

World J Diabetes
Gembillo G, Soraci L, Visconti L.
europepmc   +1 more source

Study on Predictive Models for Differential Diagnosis of Diabetic Kidney Disease and Non-Diabetic Kidney Disease Based on Clinical and Biochemical Indicators. [PDF]

Int J Med Sci
Feng P, Deng X, Gan W, Song Y, Yang Y, Zhang R, Li J, Lin W.   +7 more
europepmc   +1 more source

Pillar or poison? Evaluating overdose and safety challenges in newer diabetic kidney disease medications. [PDF]

Clin Kidney J
Maher E, Ahmed A, Wu HHL, Liew SK, Floyd L.   +4 more
europepmc   +1 more source